13.04.2014 Views

CP13/6 - CRD IV for Investment Firms - Financial Conduct Authority

CP13/6 - CRD IV for Investment Firms - Financial Conduct Authority

CP13/6 - CRD IV for Investment Firms - Financial Conduct Authority

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>CRD</strong> <strong>IV</strong> <strong>for</strong> <strong>Investment</strong> <strong>Firms</strong><br />

<strong>CP13</strong>/6<br />

Annex 1:<br />

Cost benefit analysis<br />

Summary<br />

1. On 16 December 2010, the Basel Committee published Basel III, which outlines proposals <strong>for</strong><br />

a strengthened set of prudential requirements <strong>for</strong> banks. In the EU these proposals have been<br />

implemented through the <strong>CRD</strong> <strong>IV</strong>.<br />

2. <strong>CRD</strong> <strong>IV</strong> expands the scope of firms subject to this legislative package to investment firms.<br />

Approximately 2,400 investment firms are authorised within the UK and are prudentially<br />

regulated by the FCA. We estimate that 80-90% of these firms meet the EU definition of SMEs.<br />

3. This CBA analyses the incremental impact of the overall package of <strong>CRD</strong> <strong>IV</strong> in terms of its effects<br />

on firms and markets within the FCA remit. Where appropriate and feasible, the estimated impacts<br />

of individual discretions or regulatory changes have been presented in the relevant CP chapter.<br />

4. The main impacts of <strong>CRD</strong> <strong>IV</strong> will be on systemically important institutions which are mostly<br />

regulated by the PRA. Both the costs and benefits <strong>for</strong> FCA regulated firms will not be as significant.<br />

However, in relative terms, the cost <strong>for</strong> small FCA regulated firms could be important. These<br />

costs will mainly arise from the new reporting obligations and additional capital requirements.<br />

Similarly, the main costs <strong>for</strong> the FCA will arise from the new reporting framework. Similarly to<br />

the cost, we do not expect the benefits of implementing <strong>CRD</strong> <strong>IV</strong> to investment firms will be as<br />

significant as those arising from the implementation on systemically important firms. However<br />

<strong>CRD</strong> <strong>IV</strong> will reduce potential market failures by improving transparency, corporate governance<br />

and the levels and quality of capital. Finally, we do not expect material macroeconomic<br />

impacts due to the effects of <strong>CRD</strong> <strong>IV</strong> on investment firms; these will again be mainly driven by<br />

systemically important firms and are presented in the PRA’s consultation paper.<br />

General approach to the CBA<br />

5. This Annex contains the FCA’s cost benefit analysis (CBA) <strong>for</strong> transposing the Directive provisions<br />

– where it is the responsibility of the FCA – and exercising certain discretions in the Regulation in<br />

the UK. This CBA focusses on the impacts arising from the implementation of <strong>CRD</strong> <strong>IV</strong> on FCAregulated<br />

investment firms. PRA-regulated firms are out of scope and have been considered in<br />

the CBA accompanying the PRA’s consultation paper on the implementation of <strong>CRD</strong> <strong>IV</strong>.<br />

6. When proposing new rules, we are obliged under section 138I of FSMA to publish a CBA,<br />

unless we believe there will be no increase in costs or that the increase will be of minimal<br />

significance. We are required to publish an estimate of costs and benefits unless they cannot<br />

be reasonably estimated or it is not reasonably practicable to produce an estimate.<br />

<strong>Financial</strong> <strong>Conduct</strong> <strong>Authority</strong> July 2013<br />

61

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!